Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference
August 20 2019 - 8:00AM
Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that
members of senior management will participate at the 17th Annual
Morgan Stanley Global Healthcare Conference in a session scheduled
for 11:45 a.m. ET, Tuesday, September 10, 2019 in New York,
NY.
This presentation will be webcast and can be accessed via the
Investor Relations page of the Assertio website at
http://investor.assertiotx.com. Please access the website 15
minutes prior to the start of the call to download and install any
necessary audio software. A recording of the webcast will be
archived.
About Assertio Therapeutics, Inc.Assertio
Therapeutics is committed to providing responsible solutions to
advance patient care in the Company’s core areas of neurology,
orphan and specialty medicines. Assertio currently markets three
FDA-approved products and continues to identify, license and
develop new products that offer enhanced options for patients that
may be underserved by existing therapies. To learn more about
Assertio, visit www.assertiotx.com.
INVESTOR AND MEDIA CONTACT:John B. Thomas
Senior Vice President, Investor Relations and Corporate
Communications jthomas@assertiotx.com
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Apr 2023 to Apr 2024